

HUS, Kirurginen päivystysosasto P1P, Meilahti, Helsinki Montreal, Migration Data, Canada, H3T 1E2 Vancouver, British Columbia, Canada, V1Y 1S1 Westmead, New South Wales, Australia, 2145īedford Park, South Australia, Australia, 5042

Westmead Hospital-Clinical Haematology Dept St Leonards, New South Wales, Australia, 2065 Kogarah, New South Wales, Australia, 2217 Richmond, Virginia, United States, 23298-0401Ĭoncord, New South Wales, Australia, 2139 Harrisonburg, Virginia, United States, 22801 Memorial Hermann Hospital - Texas Medical Center Texas Health Research and Education Institute Wynnewood, Pennsylvania, United States, 19096Ĭharleston, South Carolina, United States, 29425 Langhorne, Pennsylvania, United States, 19047 Saint Louis, Missouri, United States, 63141ĭurham, North Carolina, United States, 27710 Grand Blanc, Michigan, United States, 48439 Newton, Massachusetts, United States, 02462 Our Lady of the Lake Regional Medical Centerīaton Rouge, Louisiana, United States, 70808 Indianapolis, Indiana, United States, 46202 Jacksonville, Florida, United States, 32224 Jacksonville, Florida, United States, 32207 Gainesville, Florida, United States, 32610 University of Florida College of Medicine Washington, District of Columbia, United States, 20010-2975 Loma Linda, California, United States, 92354 Little Rock, Arkansas, United States, 72205 Contraindications to study medication including known hypersensitivity to the drug or its excipients (subjects with hereditary fructose intolerance may react to sorbitol).īaptist Health Center for Clinical Research.A surgery or procedure which is elective or where the risk of uncontrolled or unmanageable bleeding is low.Group B (Patients who require emergency surgery or procedure) Contraindications to study medication including known hypersensitivity to the drug or its excipients.Patients with no clinical signs of bleeding.Patients with minor bleeds (epistaxis, hematuria) who can be managed with standard supportive care.Emergency is defined as within the following 8 hours. Condition requiring emergency surgery or invasive procedure where adequate hemostasis is required.Group B (Patients who are taking dabigatran who may not be bleeding, but do require an emergency surgery or procedure for a condition other than bleeding Overt bleeding judged by the physician to require a reversal agent.Why Should I Register and Submit Results?.
